Combined Treatment with Anticancer Vaccine Using Genetically Modified Endothelial Cells and Imatinib in Bladder Cancer
Korean Journal of Urology
;
: 327-334, 2011.
Artículo
en Inglés
| WPRIM
| ID: wpr-226019
ABSTRACT
PURPOSE:
We sought to maximize the antitumor effect of an anticancer vaccine based on genetically modified endothelial cells by combining it with the platelet-derived growth factor receptor inhibitor imatinib. MATERIALS ANDMETHODS:
Human umbilical vein endothelial cells (HUVECs) were infected with 10 MOI of Ad-CMV-mGMCSF to make anticancer vaccines. One million mouse bladder cancer cells (MBT-2) were subcutaneously inoculated in C3H mice. The experimental groups included the following Group 1 (phosphate-buffered saline), Group 2 (anticancer vaccine and GM-CSF), Group 3 (imatinib), and Group 4 (anticancer vaccine, GM-CSF, and imatinib). Tumor growth and body weight were measured weekly. At 4 weeks, the tumors were immunostained with anti-CD31, and microvessel density (MVD) was measured. To evaluate the immunological mechanism of each treatment, flow cytometry analysis of activated CD4 and CD8 cells was performed.RESULTS:
At 4 weeks, the mean body weight of each group, excluding the extracted tumor weight, was not significantly different. Since week 3, the mean tumor volume in Group 4 was the smallest among the treatment groups (p<0.05), and a synergistic suppressive effect on tumor volume was observed in Group 4. The MVD in Group 4 was the most suppressed among the treatment groups (p<0.05), and a synergistic anti-angiogenic effect was observed. Flow cytometry analysis revealed that activated CD4+ and CD8+ cells increased in Group 2 and decreased in Group 3 compared with the other groups.CONCLUSIONS:
The combination of genetically modified endothelial cell vaccines and imatinib showed a synergistic antiangiogenic effect in bladder cancer.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Piperazinas
/
Pirimidinas
/
Benzamidas
/
Vejiga Urinaria
/
Neoplasias de la Vejiga Urinaria
/
Peso Corporal
/
Factor de Crecimiento Derivado de Plaquetas
/
Vacunas
/
Factor Estimulante de Colonias de Granulocitos y Macrófagos
/
Receptores del Factor de Crecimiento Derivado de Plaquetas
Límite:
Animales
Idioma:
Inglés
Revista:
Korean Journal of Urology
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS